Home Access Health Corp.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Home Access Health Corp.
OTC Tests For Flu, Strep, STIs Up For Discussion At FDA Panel Meeting
Panelists will look at the benefits and risks of over-the-counter diagnostics for influenza, strep throat and sexually transmitted infections. The meeting is being held in response to sponsor queries about new test designs.
Advisory Panel Endorses OraSure In-Home HIV Test
An FDA advisory committee endorses OraSure’s OraQuick in-home HIV test in a unanimous vote. If approved, OraQuick would be the first OTC test for HIV that untrained users can perform entirely in the home.
Advisory Panel Endorses OraSure In-Home HIV Test
An FDA advisory committee endorses OraSure’s OraQuick in-home HIV test in a unanimous vote. If approved, OraQuick would be the first OTC test for HIV that untrained users can perform entirely in the home.
The Failure and Potential of Home Diagnostics
Even for experienced companies, home testing has been a tough business, and expectations set by the success of blood glucose monitoring and pregnancy have been impossible for other tests to meet.
Company Information
- Industry
- In Vitro Diagnostics
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice